Term Pregnancy Women with Human Immunodeficiency Virus Infection Receiving Antiretroviral Threapy as A Risk Factor for Low Expression of Mitochondiral Deoxyribose-Nucleic Acid in Placenta
Article Main Content
Antiretroviral therapy (ART) given to pregnant women with Human Immunodeficiency Virus (HIV) has the effect of mitochondrial DNA (mtDNA) depletion through several steps, either directly or indirectly. This decrease may trigger the occurrence of reactive oxygen species (ROS) and mitochondrial toxicity which are characterized by energy insufficiency, cell dysfunction, and maternal and placental apoptosis. This study aimed to determine whether term pregnant women with HIV infection receiving antiretroviral therapy are risk factors for low mtDNA expression in the placenta. This cross-sectional analytic study was conducted at Sanglah Hospital Denpasar and affiliation hospitals. Inclusion samples were termed pregnant women with HIV (+) who received ART ≥ 6 months as a risk group and pregnant women with HIV (-) as a non-risk group. Expression of mtDNA was assessed by real-time Polymerase Chain Reaction (rtPCR) examination of placental samples. The estimated relative amount of mtDNA was calculated by dividing the number of mtDNA to the number of nDNA, as a reference. The cut-off value of mtDNA expression was determined by plotting a Receiver Operating Characteristics (ROC) curve. The results of the analysis found that pregnant women with HIV who received ART≥6 months had a prevalence of low mtDNA expression by 2.83 times higher than pregnant women without HIV (95% confidence interval = 1.42 – 5.67; p-value = 0.000). The conclusion of this study is that term pregnant women with HIV infection who receive ART is a risk factor for low mtRNA expression in the placental.
References
-
Siregar KN, Hanifah L, Rikawarastuti, Wahyuniar L. Prevention of HIV Transmission from Mother to Child: Challenges to the Successful Program Implementation and Practice in Indonesia. J Int Assoc Provid AIDS Care. 2021; 20: 23259582211040701.
DOI |
Google Scholar
1
-
Stover J, Glaubius R, Teng Y, Kelly S, Brown T, Hallett TB, et al. Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030. PLoS Med. 2021; 18(10): e1003831.
DOI |
Google Scholar
2
-
Badru O, Dairo MD, Oladokun RE. Quality of Life of HIV Infected Children Attending the Antiretroviral Clinic, University College Hospital, Ibadan. West Afr J Med. 2020; 37(5): 521-527.
Google Scholar
3
-
Morén C, Hernández S, Guitart-Mampel M, Garrabou G. Mitochondrial Toxicity in Human Pregnancy: An Update on Clinical and Experimental Approaches in the Last 10 Years. International Journal of Environmental Research and Public Health, 2014; 11(9): hh.9897-9918
DOI |
Google Scholar
4
-
Money D, Wagner E, Maan E, Chaworth-Musters T, Gadawski I, van Schalkwyk J, et al. Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women. Plos One. 2015; 10(8): h.e0135041.
DOI |
Google Scholar
5
-
Vermaak A, Theron G, Schubert P, Kidd M, Rabie U, Adjiba B, et al. Morphologic Changes in the Placentas of HIV-Positive Women and Their Association with Degree of Immune Suppression. International Journal of Gynecology & Obstetrics. 2012; 119(3): hh.239-243.
DOI |
Google Scholar
6
-
Ekouevi DK, Stringer E, Coetzee D, Tih P, Creek T, Stinson K, et al. Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: the PEARL study. PLoS One. 2012; 7(1): e29823.
DOI |
Google Scholar
7
-
Negara IKS, Anantasika AAN, dan Putra IWA. Characteristics of pregnant women with HIV infection following prevention of mother to child transmission of HIV (PMTCT) program in Sanglah general hospital 2005-2014. Bali Med J. 2016; 5(1): 147-151.
DOI |
Google Scholar
8
-
Sofiyanti I, Astuti FP. Relationship between the characteristics of pregnant women and HIV testing. Indonesian Journal of Midwivery. 2018; 1(1): 49-52.
DOI |
Google Scholar
9
-
Hernández S, Moren C, Catalán-García M, Lopez M, Guitart-Mampel M, Coll O, et al. Mitochondrial toxicity and caspase activation in HIV pregnant women. Journal of Cellular and Molecular Medicine. 2017; 21(1): hh. 26-34.
DOI |
Google Scholar
10
-
Young S, Murray K, Mwesigwa J, Natureeba P, dan Osterbauer B. Maternal Nutritional Status Predicts Adverse Birth Outcomes among HIV Infected Rural Ugandan Women Receiving Combination Antiretroviral Therapy. Plos ONE. 2012; 7(8): e41934.
DOI |
Google Scholar
11
-
van der Heijden WA, van de Wijer L, Jaeger M, et al. Long-term treated HIV infection is associated with platelet mitochondrial dysfunction. Sci Rep. 2021;11(1):6246. Published 2021 Mar 18. doi:10.1038/s41598-021-85775-5
DOI |
Google Scholar
12
-
Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, et al. (2003) Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 32: 370–374.
DOI |
Google Scholar
13
-
Guitart-MampeL M, Hernandez AS, Moren C, Catalan-Garcia M, Tobias E, Gonzalez-Casacuberta I, et al. Imbalance in Mitochondrial Dynamics and Apoptosis in Pregnancies Among HIV-Infected Women on HAART with Obstetric Complications. J Antimicrob Chemother. 2017; 72: hh. 2578-2586.
DOI |
Google Scholar
14
-
Ordono MS. Placental Mitochondral Dysfunction in Relation to Preterm Delivery in HIV Pregnancy. M. S. Thesis. University of British Columbia. 2014.
Google Scholar
15
Most read articles by the same author(s)
-
Made Darmayasa,
Anak Agung Ngurah Jaya Kusuma,
Made Bagus Dwi Aryana,
Prayascita Mahendrata,
Experiences of The Pregnant Women and Women who Gave Birth in Sanglah General Hospital during COVID-19 Pandemic-A Qualitative Study , European Journal of Medical and Health Sciences: Vol. 4 No. 2 (2022) -
I Made Darmayasa,
William Alexander Setiawan,
Ni Wayan Kertiasih,
Gede Vasmana Hardika,
Existential Psychotherapy to Improve the Meaningfulness of Life in Advanced Stage of Cervical Cancer Patients: A Case Study , European Journal of Medical and Health Sciences: Vol. 5 No. 5 (2023) -
I Nyoman Bayu Mahendra,
I Nyoman Gede Budiana,
I Gede Mega Putra,
Ryan Saktika Mulyana,
I Gde Sastra Winata,
Budi Setiawan Harjoto,
E6/E7 Oncogenes Mutation of Human Papillomavirus Type 16 Associated with P16 Protein Expression in Cervical Cancer , European Journal of Medical and Health Sciences: Vol. 5 No. 2 (2023) -
I Made Darmayasa,
William Alexander Setiawan,
Debrayat Osiana,
Anak Agung Ngurah Andika Damarnegara,
Changes in the Mental Status of Pregnant Women with Multiple Congenital Fetal Anomaly , European Journal of Medical and Health Sciences: Vol. 4 No. 6 (2022) -
Dewa Gede Sidan Pradnyandita,
I Wayan Megadhana,
Ketut Suwiyoga,
I Made Darmayasa,
Anom Suardika,
Endang Sri Widiyanti,
Low Expression of p53 in Sacrouterine Ligament as A Risk Factor for Stage III-IV Uterine Prolapse , European Journal of Medical and Health Sciences: Vol. 4 No. 5 (2022) -
Denni Prasetyo,
I Wayan Artana Putra,
Tjokorda G. A. Suwardewa,
I Nyoman Hariyasa Sanjaya,
Anom Suardika,
I Gde Sastra Winata,
Term Pregnancy Woman with Human Immunodeficiency Virus Infection and Antiretroviral Therapy as Risk Factor of High Caspase-3 Expression in Placenta , European Journal of Medical and Health Sciences: Vol. 4 No. 3 (2022) -
I Nyoman Gede Budiana,
I Wayan Megadhana,
Anak Agung Gede Putra Wiradnyana,
Gde Bagus Rizky Kornia,
Characteristics of Gestational Trophoblastic Disease at Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar from 1st January 2020 to 31st December 2021 , European Journal of Medical and Health Sciences: Vol. 5 No. 5 (2023) -
I Made Darmayasa,
William Alexander Setiawan,
Anak Agung Gede Agung Satrya Megada,
Ni Made Atika Nurina Yanti,
Case Study of Manak Salah Pregnancy in Bali , European Journal of Medical and Health Sciences: Vol. 5 No. 5 (2023) -
I Nyoman Bayu Mahendra,
I Nyoman Gede Budiana,
Made Suyasa Jaya,
I Gede Mega Putra,
I Nyoman Hariyasa Sanjaya,
Musa Taufiq,
Association Between E6 and E7 Human Papilloma Virus Type 16 Oncogen Mutations and P21 Protein Expression in Cervical Cancer , European Journal of Medical and Health Sciences: Vol. 5 No. 1 (2023) -
I Nyoman Bayu Mahendra,
William Alexander Setiawan,
PARP Inhibitor for Ovarian Cancer Therapy , European Journal of Medical and Health Sciences: Vol. 4 No. 6 (2022)